{
  "id": 488,
  "text": "Based on the available scientific evidence for T1a1 LVSI- patients, LN staging is not indicated.For $\\mathrm { L V S I + }$ patients, LN staging can be considered.Management of T1a1 cervical cancer by conisation can be considered as definitive treatment as hysterectomy does not improve survival.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Based on the available scientific evidence for T1a1 LVSI- patients, LN staging is not indicated.For $\\mathrm { L V S I + }$ patients, LN staging can be considered.Management of T1a1 cervical cancer by conisation can be considered as definitive treatment as hysterectomy does not improve survival.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有的科研证据，对于T1a1期且无淋巴管侵犯（LVSI-）的患者，淋巴结分期不建议进行。然而，对于存在淋巴管侵犯（LVSI+）的患者，可以考虑进行淋巴结分期。在T1a1期宫颈癌的管理中，锥切术可以被视为一种根本的治疗方案，因为手术切除子宫（子宫切除术）并不提高生存率。",
  "query": "有科研证据显示，对于T1a1 LVSI-患者，淋巴结分期是否适合进行？另外，对于LVSI+患者，是否考虑淋巴结分期？在管理T1a1宫颈癌时，锥切术是否能作为一种根本的治疗方案？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 有科研证据显示，对于T1a1 LVSI-患者，淋巴结分期是否适合进行？另外，对于LVSI+患者，是否考虑淋巴结分期？在管理T1a1宫颈癌时，锥切术是否能作为一种根本的治疗方案？\n\n<reference text>: Based on the available scientific evidence for T1a1 LVSI- patients, LN staging is not indicated.For $\\mathrm { L V S I + }$ patients, LN staging can be considered.Management of T1a1 cervical cancer by conisation can be considered as definitive treatment as hysterectomy does not improve survival.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有的科研证据，对于T1a1期且无淋巴管侵犯（LVSI-）的患者，淋巴结分期不建议进行。然而，对于存在淋巴管侵犯（LVSI+）的患者，可以考虑进行淋巴结分期。在T1a1期宫颈癌的管理中，锥切术可以被视为一种根本的治疗方案，因为手术切除子宫（子宫切除术）并不提高生存率。"
}